Emergency:
+91-124 4588 888
  • Download PHR App

Inside Robotic Oncology: How the Da Vinci System Is Changing Cancer Surgery Outcomes?

Published on 20 Mar 2026 WhatsApp Share | Facebook Share | X Share |
Link copied!
Copy Link
| Like
Robotic Surgery For Cancer in India

Cancer treatment has changed dramatically over the past decade. What once required large incisions and long recovery periods can now often be performed through highly advanced technology that gives surgeons extraordinary precision. 

One such breakthrough is the Da Vinci Surgical System, a robotic platform that allows surgeons to operate with greater control, precision, and visibility than traditional techniques. For cancer patients, this advancement means smaller incisions, reduced blood loss, faster recovery, and, in many cases, improved surgical outcomes. 

In this blog, you will learn how robotic-assisted cancer surgery works, the types of cancers it can treat, and why it is rapidly becoming a gold standard in modern oncology. 

What is The Da Vinci Robotic Surgery System?

The Da Vinci Surgical System, developed by Intuitive Surgical, is an advanced robotic platform designed to assist surgeons in performing complex procedures through minimally invasive techniques. Approved for surgical use by the U.S. Food and Drug Administration (FDA), it has been widely adopted by leading hospitals around the world, including Artemis Hospitals in India. 

Importantly, the system does not operate on its own. Instead, it acts as an extension of the surgeon’s hands. The surgeon sits at a console and controls the robotic instruments, while the system translates the surgeon’s hand movements into highly precise, scaled-down actions. These movements are carried out by robotic arms fitted with tiny wristed instruments, allowing for exceptional dexterity, stability, and control during delicate surgical procedures. 

How Robotic-Assisted Cancer Surgery Works?

Understanding the mechanics of robotic cancer surgery helps patients appreciate why it is so effective. Here is a step-by-step overview of how the Da Vinci system functions during an oncology procedure. 

Surgeon Console and Robotic Arms

The lead surgeon is seated at the surgeon console, a specially designed workstation located in the operating room. Using two hand controls (called 'masters') and foot pedals, the surgeon directs every movement of the robotic arms. The robotic cart, positioned beside the patient on the operating table, houses three or four robotic arms. These arms are inserted into the patient's body through small incisions (typically 1–2 cm), carrying micro-instruments and a high-definition camera. 

The instruments at the tip of the robotic arms have a range of motion that exceeds that of the human wrist, they can rotate 360 degrees and pivot at multiple angles, allowing access to complex anatomical regions that would be difficult to reach with conventional tools. Tremor-filtration technology ensures that any minor shaking of the surgeon's hand is completely eliminated before being translated to the robotic arms. 

Enhanced 3D Vision and Precision

One of the most powerful features of the Da Vinci system is its vision technology. The camera arm delivers a magnified, three-dimensional view of the surgical site, projected directly into the surgeon's eye-piece at the console. This level of clarity allows surgeons to distinguish tumour tissue from surrounding healthy structures with far greater accuracy than the naked eye. 

In cancer surgeries, where identifying and removing tumour margins precisely can determine long-term outcomes, this enhanced visualization is invaluable. Surgeons can operate with confidence, sparing nerves and blood vessels while achieving thorough cancer removal. 

Who is the Right Candidate for Robotic Cancer Surgery?

Not every cancer case requires robotic surgery, but for the right patient, it can make a meaningful difference in both recovery and long-term quality of life. 

So how do you know if it’s the right option for you? 

Robotic-assisted cancer surgery is often recommended for patients where precision, minimal invasiveness, and faster recovery can significantly improve outcomes. You may be a suitable candidate if: 

  • Your cancer is diagnosed at an early to moderately advanced stage, where complete tumour removal with precision is achievable 
  • You are looking for a less invasive alternative to open surgery, with smaller incisions and reduced post-operative discomfort 
  • Your condition allows for nerve-sparing or organ-preserving surgery, especially in cancers like prostate, colorectal, or gynecological cancers 
  • You have underlying health conditions, where quicker recovery and reduced surgical stress are important 
  • Your tumour is located in complex or confined anatomical areas, such as the pelvis or throat, where robotic precision offers a clear advantage 

At Artemis Hospitals, we don’t believe in a one-size-fits-all approach. Every patient undergoes a comprehensive evaluation by a multidisciplinary tumour board to determine the most effective treatment plan. 

As a trusted minimally invasive cancer surgery hospital, our focus is simple, offer the right technology to the right patient, at the right time. 

Why Early Consultation Can Change Your Cancer Journey?

When it comes to cancer, timing is not just important—it can be life-changing. Many of the benefits associated with advanced surgical techniques are most effective when the disease is diagnosed early. Delaying consultation can sometimes limit these options. 

Here’s why seeking expert care early makes a difference: 

  • Access to advanced surgical options: Early-stage cancers are more likely to be treated using precision-based approaches like Da Vinci surgery in India, where minimally invasive techniques can be fully utilized. 
  • Better surgical outcomes: Early intervention improves the chances of complete tumour removal while reducing complications 
  • Faster recovery and less disruption to life: Patients can often return to normal activities sooner when surgery is performed at the right stage 
  • Higher chances of preserving function: Early treatment allows surgeons to protect critical nerves and organs, which can directly impact quality of life 
  • More personalised treatment choices: Timely diagnosis opens the door to a wider range of treatment strategies, tailored to your specific condition 

What are the Benefits of Robotic Surgery for Cancer Patients?

The Da Vinci system offers a range of advantages over both conventional open surgery and standard laparoscopic techniques. Here are the most significant benefits for cancer patients: 

Greater Surgical Precision

Robotic surgery enables millimeter-level accuracy during tumor excision. Surgeons can remove cancerous tissue with clean margins while minimizing damage to adjacent nerves, blood vessels, and organs. This results in significantly less intraoperative blood loss, reducing the risk of requiring blood transfusions. This precision is particularly critical in surgeries for prostate cancer (where nerve-sparing techniques can preserve continence and sexual function), colorectal cancers and gynecological cancers

Minimal Blood Loss and Smaller Incisions

Compared to open surgery, robotic-assisted procedures require only small keyhole incisions. Smaller incisions mean a considerably reduced risk of post-operative infection and wound complications, a crucial concern for cancer patients who may be undergoing concurrent chemotherapy or radiation. 

Faster Recovery and Shorter Hospital Stay

Patients undergoing robotic cancer surgery typically experience faster recovery times. Most patients are ambulatory (able to walk) within 24 hours of surgery and are discharged from the hospital in 2 to 4 days, compared to 7–10 days following open surgery. Reduced tissue trauma leads to less post-operative pain, lower dependency on pain medications, and a quicker return to daily activities, allowing patients to resume adjuvant treatments such as chemotherapy sooner if required. 

Which Cancers are Commonly Treated With Robotic Surgery?

Robotic surgery is now used across a wide range of cancer types. Its application continues to expand as surgical teams gain expertise and the technology evolves. 

Prostate Cancer

Robotic-assisted radical prostatectomy is one of the most well-established applications of the Da Vinci system globally. The procedure involves the complete removal of the prostate gland and is the gold standard for localized prostate cancer treatment. The precision of robotic surgery is especially valuable here, as the prostate lies adjacent to the bladder, rectum, and delicate nerve bundles controlling urinary and sexual function. Surgeons can perform nerve-sparing prostatectomies that preserve quality of life without compromising oncological outcomes. 

Gynecological Cancers

Cancers of the uterus (endometrial cancer), cervix, and ovaries are increasingly treated robotically. Robotic hysterectomy, lymph node dissection, and tumour debulking can all be performed with greater accuracy and less blood loss than open or conventional laparoscopic approaches. For endometrial cancer in particular, robotic surgery has become the preferred approach at many leading cancer centres. 

Colorectal Cancer

Robotic surgery has transformed the treatment of colorectal cancers, particularly rectal cancer, where the confined space of the pelvic cavity makes conventional open or laparoscopic surgery technically challenging. Robotic platforms offer improved access and visualisation in the deep pelvis, enabling precise dissection and sphincter-sparing resections that can preserve normal bowel function. 

Head and Neck Cancers

Transoral robotic surgery (TORS) has revolutionised the treatment of oropharyngeal cancers, including cancers of the throat, base of tongue, and tonsils, allowing surgeons to remove tumours through the mouth without external incisions. This approach eliminates the need for extensive jaw-splitting procedures and is associated with improved functional outcomes and faster recovery. 

Robotic Surgery vs Traditional Open Cancer Surgery

For patients and families weighing their options, understanding the practical differences between robotic and open surgery is essential. 

Accuracy and Control

Open surgery provides the surgeon with direct tactile feedback, the ability to feel tissue. However, it also comes with the limitations of the human hand: restricted range of motion in tight spaces, potential for fatigue-related tremor, and dependence on the surgeon's direct line of sight. Robotic surgery overcomes all of these constraints. The 3D magnified view, tremor elimination, and multi-jointed instruments collectively enable a level of accuracy that open surgery simply cannot replicate in anatomically complex cancer resections. 

Pain, Scarring, and Recovery Time

Open cancer surgeries typically involve large abdominal or chest incisions ranging from 10 to 30 centimeters. These wounds take weeks to heal, cause significant post-operative pain, and leave visible scarring. Robotic surgery, by contrast, uses 3–5 small ports of 8–12mm each. Patients consistently report less pain, need fewer analgesics, experience minimal scarring, and return to normal life in a fraction of the time. 

Impact of the Da Vinci System on Cancer Surgery Outcomes and Patient Recovery

Clinical evidence from thousands of robotic cancer surgeries performed worldwide has demonstrated consistently positive outcomes. Studies published in leading oncology journals report that robotic-assisted procedures using systems such as the Da Vinci Surgical System achieve oncological results comparable to, and in some cases better than, traditional open surgery. 

According to The Tribune, large multi-center studies have shown that robotic surgery can lead to 20–50% less blood loss, 30–40% shorter hospital stays, and complication rates reduced by nearly 15–25% compared to conventional open procedures. Patients undergoing robotic-assisted cancer surgery also tend to experience smaller incisions, reduced post-operative pain, and faster return to daily activities. 

Importantly, research in cancers such as prostate, colorectal, and gynecologic malignancies has demonstrated similar cancer control rates, including comparable tumor removal margins and long-term survival outcomes, while significantly improving the patient’s recovery experience. These results have helped establish robotic-assisted surgery as a preferred minimally invasive option in many modern oncology programs. 

Limitations and Considerations of Robotic Cancer Surgery

While robotic surgery represents a major advance in cancer treatment, it is important to approach it with balanced expectations. 

  • Cost: Robotic surgery systems are expensive to procure and maintain, which can translate to higher procedure costs compared to conventional surgery. Patients should discuss costs and insurance coverage with their hospital team. 
  • Learning curve: The outcomes of robotic cancer surgery are strongly influenced by the experience of the surgical team. Patients should seek centres with established robotic oncology programs and surgeons who perform a high volume of robotic procedures. 
  • Not suitable for all cases: Robotic surgery is not appropriate for every cancer patient. Patients with very advanced locally invasive tumours, certain anatomical considerations, or significant prior surgical history may not be ideal candidates. A multidisciplinary tumour board assessment should always guide treatment decisions. 
  • No haptic feedback: Unlike open surgery, robotic systems currently do not provide the surgeon with tactile (touch) feedback. While experienced robotic surgeons adapt by relying on visual cues, this remains an area of active technological development. 

Future of Robotic Technology in Oncology

The evolution of robotic surgery is accelerating. The next generation of robotic platforms, including the Da Vinci 5 system, incorporates artificial intelligence-guided tissue recognition, fluorescence imaging to identify tumour boundaries in real time, and haptic feedback systems that restore the sense of touch to robotic procedures. 

Telesurgery is the ability to perform surgery remotely via robotic platforms over high-speed networks. This is being piloted in several countries, with the potential to bring expert oncological surgical care to patients in remote or underserved regions. Single-port robotic systems, which require only one incision, are also advancing rapidly, promising even less invasive approaches. 

Machine learning integration will soon allow robotic systems to learn from thousands of prior surgeries, offering intraoperative guidance and risk prediction that can further improve outcomes. The future of robotic oncology is not just about better tools, it is about a smarter, more personalised approach to cancer surgery. 

How Artemis Hospitals are Advancing Robotic Cancer Care?

Artemis Hospitals stands at the forefront of robotic oncology in India, offering patients access to world-class cancer surgery delivered with precision, expertise, and compassion. 

We are equipped with the latest generation Da Vinci robotic surgical systems, enabling our oncology team to perform complex cancer resections with unmatched accuracy. Our robotic operating theaters are designed to the highest international standards, ensuring an optimal environment for precision cancer surgery. 

Each patient's case is reviewed by a multidisciplinary tumour board, comprising onco-surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists, to ensure that robotic surgery is the right choice and that the operative plan is optimised for the best possible outcome. 

At Artemis Hospitals, we understand that a cancer diagnosis is one of the most challenging experiences a person and their family can face. Our approach goes beyond surgery; we provide comprehensive pre-operative counselling, dedicated robotic surgery coordinators, personalised recovery plans, and ongoing follow-up care. Every patient receives a treatment plan tailored to their specific cancer type, stage, anatomy, and personal priorities. 

Article by Dr. Preeti Vijayakumaran
Consultant - Oncology
Artemis Hospitals

Frequently Asked Questions

Is robotic cancer surgery safe for patients?

Yes. Robotic cancer surgery is very safe when performed by experienced surgeons at accredited hospitals, like Artemis. As with any surgery, individual risks vary; your surgeon will discuss specific risks relevant to your case during pre-operative consultation. 

Yes, the minimally invasive nature of robotic surgery results in substantially less intraoperative blood loss compared to open surgery. This reduces the likelihood of requiring blood transfusions and contributes to faster post-operative recovery.

Recovery varies, but most patients are discharged within 2–4 days of a robotic procedure. Full recovery typically occurs within 2–4 weeks. Our surgical team will provide a personalised recovery plan and timeline. 

While both are minimally invasive, robotic surgery offers several advantages over conventional laparoscopy, such as 3D magnified view, instruments with a greater range of motion, tremor elimination, and an ergonomic surgeon console that reduces fatigue during long procedures.

Outcomes from robotic cancer surgery are directly correlated with surgeon experience and case volume. Patients should seek treatment at a renowned hospital like Artemis with a team of experienced surgeons. 

Robotic surgery typically has a higher upfront procedure cost than open surgery due to the cost of the robotic system and disposable instruments. However, when total treatment costs are considered, including shorter hospital stays, lower complication rates, reduced need for blood products, and faster return to work, robotic surgery often proves cost-effective. 

Patients can expect a thorough pre-operative workup including imaging (CT/MRI/PET scans), blood tests, anaesthesia assessment, and a detailed consultation with their robotic surgeon. The surgical team will explain the procedure, expected benefits, risks, and recovery plan. 

Artemis Hospitals Gurugram, Haryana, is one of India's premier destinations for robotic cancer surgery. Conveniently located in the National Capital Region (NCR), we serve patients from Delhi, Noida, Faridabad, and across India. Our robotic oncology program is fully operational and accepting new patients contact us at +91 9800400498 to schedule a consultation.

Artemis Hospitals has a dedicated team of robotic oncology specialists across surgical disciplines, including urological oncology, gynaecological oncology, colorectal surgery, and head and neck oncology.

Artemis Hospitals is consistently ranked among the top cancer surgery hospitals in India. We combine advanced Da Vinci robotic technology, a highly experienced multidisciplinary oncology team, international-standard infrastructure, and a patient-first philosophy.

World Of Artemis

Artemis Hospitals, established in 2007, is a healthcare venture launched by the promoters of the 4$ Billion Apollo Tyres Group. It is spread across a total area of 525,000 square feet.

To know more
For any inquiries, appointment bookings, or general concerns, reach us at contactus@artemishospitals.com.
For International Patient Services, reach us at internationaldesk@artemishospitals.com.
For any feedback-related issues, reach us at feedback@artemishospitals.com.

Request a call back


Get Direction